Smith And Nephew Company Profile
What is the competitive landscape for SMITH AND NEPHEW
SMITH AND NEPHEW has forty-two approved drugs.
Summary for Smith And Nephew
| US Patents: | 0 |
| Tradenames: | 20 |
| Ingredients: | 19 |
| NDAs: | 42 |
Drugs and US Patents for Smith And Nephew
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith And Nephew | PHENYTOIN SODIUM | phenytoin sodium | INJECTABLE;INJECTION | 088519-001 | Dec 19, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Smith And Nephew | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 088531-001 | Mar 4, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Smith And Nephew | NALOXONE HYDROCHLORIDE | naloxone hydrochloride | INJECTABLE;INJECTION | 071671-001 | Nov 17, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Smith And Nephew | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 088239-001 | Jul 26, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Smith And Nephew | FUROSEMIDE | furosemide | INJECTABLE;INJECTION | 070078-001 | Feb 5, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Smith And Nephew | HALOPERIDOL | haloperidol lactate | INJECTABLE;INJECTION | 070802-001 | Dec 14, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
